Security key
G2161P140
China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (SXTC)
CUSIP: G2161P140
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common stock, $0.08 par value
- Total 13F shares
- 73,359
- Total 13F value
- $79,938
- Share change
- +70,489
- SEC-reported price per share
- $1.08
- Number of holders
- 6
- Value change
- +$77,818
- Number of buys
- 5
Report period
Q2 2024
Institutions
6
Top holders
6
SXTC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
China SXT Pharmaceuticals, Inc. SEC filings
China SXT Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP G2161P140
Recent filing periods:
Ownership snapshot
Top reported holders of SXTC - China SXT Pharmaceuticals, Inc. - Common stock, $0.08 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACADIAN ASSET MANAGEMENT LLC
Disclosed value leader
ACADIAN ASSET MANAGEMENT LLC
Comparable rows
0/4
Latest evidence
31 Mar 2024
13F
3/4/5
Highest disclosed value: $3,000
4 rows are not safely comparable across share classes.
Quick read
ACADIAN ASSET MANAGEMENT LLC has the largest disclosed position value at $3K.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ACADIAN ASSET MANAGEMENT LLC's linked filing trail.
Disclosed position value
Top 3
ACADIAN ASSET MANAGEMENT LLC
$3K
Qube Research & Technologies Ltd
$173
UBS Group AG
$13
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
—
class O/S missing
|
$3,000
2,759 shares
|
— | 31 Mar 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
—
class O/S missing
|
$173
103 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
—
class O/S missing
|
$13
8 shares
|
— | 31 Mar 2024 |
| Feng Felix Zhou |
3/4/5
Co-CEO and Director, Director
|
—
class O/S missing
|
—
4 shares
|
— | 04 Jul 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
73,359
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
3
Q2 2024 holders
6
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend